OrbiMed Advisors LLC's Form 4 filing
NeuroPace Inc (NPCE) · filed May 3, 2024
- Accession no.
- 0000947871-24-000429
- Filed
- May 3, 2024, 5:16 PM ET
- Trade date
- May 1-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $409.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Common Stock | SSaleDisposed | −15,690 | $14.02 | −$219,973.8 | 3,419,851 | Indirect | |
| May 2, 2024 | Common Stock | SSaleDisposed | −8,842 | $14.01 | −$123,876.42 | 3,411,009 | Indirect | |
| May 3, 2024 | Common Stock | SSaleDisposed | −4,674 | $14.03 | −$65,576.22 | 3,406,335 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.